This report summarizes the notable movements among health care stocks during Tuesday's pre-market trading. It details companies that experienced significant gains and losses, offering a snapshot of early market dynamics within the health care sector.
Health Sector Sees Volatility in Early Trading
On Tuesday morning, December 2, 2025, the health care sector demonstrated considerable activity in pre-market trading, with several companies experiencing pronounced share price shifts. Among the leading advancers was Mobile-health Network (NASDAQ: MNDR), whose stock surged by 19.4%, reaching a value of $2.21. Following closely was ETHZilla (NASDAQ: ETHZ), which saw its shares appreciate by 17.52% to $11.13. Jasper Therapeutics (NASDAQ: JSPR) also posted a strong performance, with its stock climbing 17.44% to $2.02. Other notable gainers included NRX Pharmaceuticals (NASDAQ: NRXP), increasing by 10.87% to $2.65, Aethlon Medical (NASDAQ: AEMD), up by 9.73% to $4.62, and Fennec Pharmaceuticals (NASDAQ: FENC), which rose by 8.79% to $8.41.
Conversely, some health care stocks faced headwinds during the same pre-market period. Leading the decliners was Janux Therapeutics (NASDAQ: JANX), experiencing a substantial decrease of 38.7% to $20.84 per share. Sensei Biotherapeutics (NASDAQ: SNSE) also saw a significant drop, falling by 12.01% to $7.40. Shares of ProPhase Labs (NASDAQ: PRPH) declined by 10.36% to $0.17, while Citius Oncology (NASDAQ: CTOR) decreased by 8.54% to $1.50. Clearmind Medicine (NASDAQ: CMND) fell by 8.34% to $0.13, and Nexalin Technology (NASDAQ: NXL) recorded a 7.62% reduction, trading at $0.85.
These early market movements underscore the dynamic nature of the health care industry, often influenced by a myriad of factors including regulatory news, clinical trial results, and broader economic trends. Investors closely monitor these shifts to gauge market sentiment and identify potential opportunities or risks.